GH Research
GHRS
17.53
-1.03
-5.55%
GH Research
US · GHRS
#2969 by market cap
Listed 2021
17.53
-1.03
-5.55%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44Market Newswire · 2026/8/31
-
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65Market Newswire · 2026/11/9
-
Rating change
A Quick Look at Today's Ratings for GH Research(GHRS.US), With a Forecast Between $32 to $39Market Newswire · 2026/5/15
-
Rating change
Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)TipRanks · 2026/3/7
-
Rating change
RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/5/16
-
Rating change
Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2026/5/16
-
Rating change
Wells Fargo Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $44Market Newswire · 2026/7/27
-
Rating change
Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $39Market Newswire · 2026/8/7
-
Rating change
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $65Market Newswire · 2026/5/19
-
Rating change
Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $34Market Newswire · 2026/3/10
-
Rating change
Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40Market Newswire · 2026/8/7
-
Rating change
H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)TipRanks · 2026/4/29
-
Rating change
Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/3/6
-
RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $42Market Newswire · 2026/11/10
-
CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39Market Newswire · 2026/8/8
-
Rating change
Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), MapLight Therapeutics, Inc. (MPLT)TipRanks · 2026/5/15
-
Rating change
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/4/29
-
Rating change
Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40Market Newswire · 2026/8/7
-
TD Cowen Maintains GH Research(GHRS.US) With Buy RatingMarket Newswire · 2026/8/7
-
Rating change
Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $42Market Newswire · 2026/3/6
-
Rating change
Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/3/6
-
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65Market Newswire · 2026/8/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
GH Research discussion 0 comments